Maternal late-pregnancy BMI is associated with compartment-specific immune-metabolic signatures across the maternal–placental–fetal axis
IntroductionElevated maternal body mass index (BMI) during pregnancy is associated with adverse maternal and offspring outcomes; yet the molecular pathways linking maternal metabolic status to placental function and fetal immune development remain poorly understood.MethodsWe performed multi-compartment transcriptomic profiling across the maternal–placental–fetal axis, complemented by exploratory cytokine profiling in a larger available plasma sample set.